Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Hair Growth Supplement and Treatment Market

Hair Growth Supplement and Treatment Market Size

  • Report ID: GMI9725
  • Published Date: Jun 2024
  • Report Format: PDF

Hair Growth Supplement and Treatment Market Size

Hair Growth Supplement and Treatment Market size was valued at USD 7.8 billion in 2023 growing at a CAGR of 6.1% from 2024 and 2032, driven by factors such as the increasing prevalence of hair disorders such as alopecia areata, telogen effluvium, and other scalp conditions that has heightened the need for effective treatments as people seek to improve their appearance and confidence.

 

For instance, as per the report published by National Alopecia Areata Foundation, alopecia areata affects about 160 million people worldwide and nearly 6.7 million people in the U.S. alone. Although alopecia areata can begin at any age, most individuals develop the disease early in life. More than 80% show signs of the disease before age 40, and 40% experience symptoms by age 20. Thus, the rapid increase in the prevalence of hair disorder globally is the major factor that is anticipated to increase the demand for hair growth supplements and pharmaceutical dosage forms, thereby boosting the market growth.
 

Hair growth supplement contain ingredients that are believed to help the hair grow, such as specific or a variety of nutrients and/or botanicals. Hair supplements may help to support hair growth and hair health in people who have a deficiency or suboptimal levels of certain nutrients. In addition, the hair loss treatments are meant to help with androgenic alopecia in male and female pattern hair loss. These treatments include medications and device including laser caps.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Hair growth supplement and treatment market size was USD 7.8 billion in 2023 and is expected to register 6.1% CAGR from 2024-2032 owing to the increasing prevalence of hair disorders such as alopecia areata, telogen effluvium, and other scalp conditions worldwide.

The pharmaceuticals segment reached USD 5.6 billion in 2023 and is expected to register a commendable CAGR from 2024-2032 due to increasing incidence of hair loss conditions such as androgenetic alopecia and alopecia areata.

North America hair growth supplement and treatment industry held 44.5% share in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to companies investing heavily in research and development and distribution in the region.

Amway Corporation, GNC Holdings, Inc., HUM Nutrition, Nature

Hair Growth Supplement and Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 17
  • Tables & Figures: 130
  • Countries covered: 22
  • Pages: 176
 Download Free Sample